英賽德藥學INCY
那斯達克 · USD
92.95
+0.71
(+0.77%)
收盤 03/20 03:59 (UTC+8)
03/20 03:59 (UTC+8)
英賽德藥學INCY
92.95
+0.71
(+0.77%)
財務數據
損益表
- 9.19
- 10.13
- 8.81
- 10.44
- 11.38
- 11.79
- 10.53
- 12.16
- 13.66
- 15.07
- -3.73
- 10.26
- -13.07
- 18.49
- 9.02
- 3.59
- -10.67
- 15.45
- 12.38
- 10.31
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 1,506,835 | 1,365,980 | 1,215,529 | 1,052,898 | 1,178,698 | 1,137,871 | 1,043,759 | 880,889 | 1,013,341 | 919,025 |
營業成本 | 121,175 | 99,001 | 78,766 | 73,188 | 88,485 | 85,993 | 76,634 | 60,956 | 69,751 | 60,091 |
營業毛利 | 1,385,660 | 1,266,979 | 1,136,763 | 979,710 | 1,090,213 | 1,051,878 | 967,125 | 819,933 | 943,590 | 858,934 |
營業費用 | 1,049,801 | 823,461 | 606,449 | - | 788,700 | 905,793 | - | 728,035 | 756,320 | 644,229 |
研發費用 | 611,372 | 506,584 | 494,917 | 437,279 | 466,034 | 573,174 | 1,138,380 | 429,260 | 444,494 | 375,709 |
推銷及管理費用 | 362,154 | 316,877 | 111,532 | 337,263 | 322,666 | 332,619 | 306,875 | 298,775 | 311,826 | 268,520 |
非經常性項目費用 | 76,275 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 335,859 | 443,518 | 530,314 | 205,168 | 301,513 | 146,085 | -478,130 | 91,898 | 187,270 | 214,705 |
其他收入及費用 | 36,418 | 30,824 | 32,443 | 31,025 | 22,811 | 24,195 | 49,769 | 144,691 | 94,329 | 56,210 |
利息費用 | 582 | 592 | 594 | 660 | 419 | 774 | 657 | 430 | 804 | 623 |
稅前純益 | 389,941 | 482,308 | 558,012 | 234,190 | 313,724 | 156,524 | -389,777 | 236,159 | 270,956 | 233,799 |
所得稅 | 90,662 | 58,139 | 153,013 | 75,987 | 112,512 | 50,068 | 54,824 | 66,611 | 69,877 | 62,530 |
稅後純益 | 299,279 | 424,169 | 404,999 | 158,203 | 201,212 | 106,456 | -444,601 | 169,548 | 201,079 | 171,269 |
基本每股稅後盈餘(元) | 1.51 | 2.17 | 2.09 | 0.82 | 1.04 | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 |
稀釋每股稅後盈餘(元) | 1.46 | 2.11 | 2.04 | 0.80 | 0.95 | 0.44 | -1.99 | 0.75 | 0.89 | 0.76 |
基本平均股數(千股) | 197439.00 | 195670.00 | 193995.00 | 193712.00 | 193152.00 | 192629.00 | 218175.00 | 224484.00 | 224226.00 | 224078.00 |
稀釋平均股數(千股) | 204430.00 | 201429.00 | 198744.00 | 198197.00 | 197423.00 | 195838.00 | 218175.00 | 227219.00 | 226125.00 | 226167.00 |
還原基本每股稅後盈餘(元) | 1.51 | 2.17 | 2.09 | 0.82 | 1.04 | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 |
還原稀釋每股稅後盈餘(元) | 1.46 | 2.11 | 2.04 | 0.80 | 0.95 | 0.44 | -1.99 | 0.75 | 0.89 | 0.76 |
還原基本平均股數(千股) | 197,439 | 195,670 | 193,995 | 193,712 | 193,152 | 192,629 | 218,175 | 224,484 | 224,226 | 224,078 |
還原稀釋平均股數(千股) | 204,430 | 201,429 | 198,744 | 198,197 | 197,423 | 195,838 | 218,175 | 227,219 | 226,125 | 226,167 |
EBITDA(千元) | 414,505 | 506,923 | 581,525 | 257,212 | 336,876 | 179,818 | -367,072 | 258,536 | 293,522 | 255,812 |